You are here

Associations between metabolic dysregulation and circulating biomarkers of fibrosis: the Cardiovascular Health Study.

TitleAssociations between metabolic dysregulation and circulating biomarkers of fibrosis: the Cardiovascular Health Study.
Publication TypeJournal Article
Year of Publication2015
AuthorsAgarwal, I, Glazer, NL, Barasch, E, Djoussé, L, Gottdiener, JS, Ix, JH, Kizer, JR, Rimm, EB, Siscovick, DS, King, GL, Mukamal, KJ
JournalMetabolism
Volume64
Issue10
Pagination1316-23
Date Published2015 Oct
ISSN1532-8600
KeywordsAged, Aged, 80 and over, Biomarkers, Blood Glucose, Cardiovascular System, Cross-Sectional Studies, Diabetes Complications, Diabetes Mellitus, Fatty Acids, Nonesterified, Female, Fibrosis, Health, Humans, Insulin, Insulin Resistance, Male, Metabolic Diseases, Peptide Fragments, Procollagen, Transforming Growth Factor beta
Abstract<p><b>AIM: </b>Fibrosis is one postulated pathway by which diabetes produces cardiac and other systemic complications. Our aim was to determine which metabolic parameters are associated with circulating fibrosis-related biomarkers transforming growth factor-β (TGF-β) and procollagen type III N-terminal propeptide (PIIINP).</p><p><b>METHODS: </b>We used linear regression to determine the cross-sectional associations of diverse metabolic parameters, including fasting glucose, fasting insulin, body mass index, fatty acid binding protein 4, and non-esterified fatty acids, with circulating levels of TGF-β (n = 1559) and PIIINP (n = 3024) among community-living older adults in the Cardiovascular Health Study.</p><p><b>RESULTS: </b>Among the main metabolic parameters we examined, only fasting glucose was associated with TGF-β (P = 0.03). In contrast, multiple metabolic parameters were associated with PIIINP, including fasting insulin, body mass index, and non-esterified fatty acids (P<0.001, P<0.001, P=0.001, respectively). These associations remained statistically significant after mutual adjustment, except the association between BMI and PIIINP.</p><p><b>CONCLUSIONS: </b>Isolated hyperglycemia is associated with higher serum concentrations of TGF-β, while a broader phenotype of insulin resistance is associated with higher serum PIIINP. Whether simultaneous pharmacologic targeting of these two metabolic phenotypes can synergistically reduce the risk of cardiac and other manifestations of fibrosis remains to be determined.</p>
DOI10.1016/j.metabol.2015.07.013
Alternate JournalMetab. Clin. Exp.
PubMed ID26282733
PubMed Central IDPMC4939831
Grant List268200800007C / / PHS HHS / United States
268201200036C / / PHS HHS / United States
AG023629 / AG / NIA NIH HHS / United States
F30 HL118775 / HL / NHLBI NIH HHS / United States
HL080295 / HL / NHLBI NIH HHS / United States
HL094555 / HL / NHLBI NIH HHS / United States
HL118775 / HL / NHLBI NIH HHS / United States
N01 HC085086 / HC / NHLBI NIH HHS / United States
N01HC55222 / HC / NHLBI NIH HHS / United States
N01HC85079 / HC / NHLBI NIH HHS / United States
N01HC85080 / HC / NHLBI NIH HHS / United States
N01HC85081 / HC / NHLBI NIH HHS / United States
N01HC85082 / HC / NHLBI NIH HHS / United States
N01HC85083 / HC / NHLBI NIH HHS / United States
N01HC85086 / HC / NHLBI NIH HHS / United States
R01 AG023629 / AG / NIA NIH HHS / United States
R01 HL080295 / HL / NHLBI NIH HHS / United States
R01 HL094555 / HL / NHLBI NIH HHS / United States